These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29532233)

  • 1. Nephrotic syndrome associated with severe hypertriglyceridemia in a pediatric patient: Answers.
    Corredor-Andrés B; Muñoz-Calvo MT; Calero O; Aparicio C; Argente J; Calero M
    Pediatr Nephrol; 2018 Nov; 33(11):2075-2078. PubMed ID: 29532233
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrotic syndrome associated with severe hypertriglyceridemia in a pediatric patient: Questions.
    Corredor-Andrés B; Muñoz-Calvo MT; Calero O; Aparicio C; Argente J; Calero M
    Pediatr Nephrol; 2018 Nov; 33(11):2073-2074. PubMed ID: 29532231
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe hypertriglyceridemia and recurrent pancreatitis in a girl with type Ia glycogen storage disease and type III hyperlipoproteinemia.
    Vivatrat N; Barshop BA; Jones KL
    Am J Med Genet A; 2009 Nov; 149A(11):2557-9. PubMed ID: 19842193
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel apolipoprotein E2 variant, E2Toranomon (Q187E), identified in a type III hyperlipoproteinemia patient with coronary atherosclerosis.
    Okubo M; Aoyama Y; Harada K; Fukawa M; Tsukada T; Mokuno H; Yamada N; Murase T
    Atherosclerosis; 1998 Sep; 140(1):187-90. PubMed ID: 9733231
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
    Feussner G; Funke H; Weng W; Assmann G; Lackner KJ; Ziegler R
    Eur J Clin Invest; 1992 Sep; 22(9):599-608. PubMed ID: 1360898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case of familial hyperlipoproteinemia type III hypertriglyceridemia induced acute pancreatitis: Role for outpatient apheresis maintenance therapy.
    Saleh MA; Mansoor E; Cooper GS
    World J Gastroenterol; 2017 Oct; 23(40):7332-7336. PubMed ID: 29142480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of plasmapheresis on familial type III hyperlipoproteinemia associated with glomerular lipidosis, nephrotic syndrome and diabetes mellitus.
    Suzaki K; Kobori S; Ueno S; Uehara M; Kayashima T; Takeda H; Fukuda S; Takahashi K; Nakamura N; Uzawa H
    Atherosclerosis; 1990 Jan; 80(3):181-9. PubMed ID: 2310424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe hyperlipidemia due to multiple factors in a child with nephrotic syndrome.
    Ongkingco JR; Mann WA; Ruley EJ; Gregg RE
    Child Nephrol Urol; 1991; 11(2):107-10. PubMed ID: 1756519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and consequences of apolipoprotein-epsilon(3Groningen): a G-insertion in codon 95/96 that is predicted to cause a premature stop codon.
    Dijck-Brouwer DA; van Doormaal JJ; Kema IP; Brugman AM; Kingma AW; Muskiet FA
    Ann Clin Biochem; 2005 Jul; 42(Pt 4):264-8. PubMed ID: 15989726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypertricglyceridemia: prognostic impact and treatment options].
    Custodis F; Laufs U
    Dtsch Med Wochenschr; 2011 Jul; 136(30):1533-42. PubMed ID: 21789752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of type III hyperlipoproteinemia.
    Guyton JR
    Am Heart J; 1999 Jul; 138(1 Pt 1):17-8. PubMed ID: 10385757
    [No Abstract]   [Full Text] [Related]  

  • 12. Rare variants in the lipoprotein lipase (LPL) gene are common in hypertriglyceridemia but rare in Type III hyperlipidemia.
    Evans D; Arzer J; Aberle J; Beil FU
    Atherosclerosis; 2011 Feb; 214(2):386-90. PubMed ID: 21159338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel CREB3L3 Nonsense Mutation in a Family With Dominant Hypertriglyceridemia.
    Cefalù AB; Spina R; Noto D; Valenti V; Ingrassia V; Giammanco A; Panno MD; Ganci A; Barbagallo CM; Averna MR
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2694-9. PubMed ID: 26427795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Familial hyperlipoproteinemia type III].
    Yamamura T
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1772-7. PubMed ID: 1479217
    [No Abstract]   [Full Text] [Related]  

  • 15. [Apolipoprotein E and apolipoprotein E phenotype].
    Matsunaga A
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():114-6. PubMed ID: 15658277
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hyperlipoproteinemia type III: genetic basis and environmental factors, diagnosis, and treatment].
    Pocoví M; Garcés C; Casao E; Cenarro A; Civeira F
    Rev Clin Esp; 1992 Nov; 191(8):444-50. PubMed ID: 1488520
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetics of type III hyperlipoproteinemia.
    Feussner G; Piesch S; Dobmeyer J; Fischer C
    Genet Epidemiol; 1997; 14(3):283-97. PubMed ID: 9181357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spectrum of type III hyperlipoproteinemia.
    Sniderman AD; de Graaf J; Thanassoulis G; Tremblay AJ; Martin SS; Couture P
    J Clin Lipidol; 2018; 12(6):1383-1389. PubMed ID: 30318453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Specific diagnosis of familial dysbetalipoproteinemia in Denmark. Report of a family study].
    Gerdes LU; Faergeman O
    Ugeskr Laeger; 1988 Jan; 150(4):230-2. PubMed ID: 3376331
    [No Abstract]   [Full Text] [Related]  

  • 20. Apolipoprotein E1-Hammersmith (Lys146-->Asn;Arg147-->Trp), due to a dinucleotide substitution, is associated with early manifestation of dominant type III hyperlipoproteinaemia.
    Hoffer MJ; Niththyananthan S; Naoumova RP; Kibirige MS; Frants RR; Havekes LM; Thompson GR
    Atherosclerosis; 1996 Aug; 124(2):183-9. PubMed ID: 8830931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.